These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1258792)

  • 1. Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion.
    Braunwald E; Maroko PR
    Am J Cardiol; 1976 Mar; 37(4):550-6. PubMed ID: 1258792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term preservation of ischemic myocardium in the dog by hyaluronidase.
    Kloner RA; Braunwald E; Maroko PR
    Circulation; 1978 Aug; 58(2):220-6. PubMed ID: 668070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of experimental myocardial infarct size by corticosteroid administration.
    Libby P; Maroko PR; Bloor CM; Sobel BE; Braunwald E
    J Clin Invest; 1973 Mar; 52(3):599-607. PubMed ID: 4685084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion.
    Radvany P; Maroko PR; Braunwald E
    Am J Cardiol; 1975 Jun; 35(6):795-800. PubMed ID: 1130288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of hyaluronidase and hydrocortisone in the reduction of myocardial infarct size following coronary occlusion. Experimental and clinical observations.
    Braunwald E; Maroko PR
    Acta Med Scand Suppl; 1976; 587():169-76. PubMed ID: 1062125
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of changes in the epicardial QRS complex to assess interventions which modify the extent of myocardial necrosis following coronary artery occlusion.
    Hillis LD; Askenazi J; Braunwald E; Radvany P; Muller JE; Fishbein MC; Maroko PR
    Circulation; 1976 Oct; 54(4):591-8. PubMed ID: 963848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients.
    Maroko PR; Davidson DM; Libby P; Hagan AD; Braunwald E
    Ann Intern Med; 1975 Apr; 82(4):516-20. PubMed ID: 1119765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of hyaluronidase to alter the early course of acute myocardial infarction in pigs.
    Most AS; Capone RJ; Mastrofrancesco PA
    Am J Cardiol; 1976 Jul; 38(1):28-33. PubMed ID: 945684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
    Maroko PR; Braunwald E
    Circulation; 1976 Mar; 53(3 Suppl):I162-8. PubMed ID: 767015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronidase-induced reductions in myocardial infarct size.
    Maclean D; Fishbein MC; Maroko PR; Braunwald E
    Science; 1976 Oct; 194(4261):199-200. PubMed ID: 959848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction.
    Maroko PR; Hillis LD; Muller JE; Tavazzi L; Heyndrickx GR; Ray M; Chiariello M; Distante A; Askenazi J; Salerno J; Carpentier J; Reshetnaya NI; Radvany P; Libby P; Raabe DS; Chazov EI; Bobba P; Braunwald E
    N Engl J Med; 1977 Apr; 296(16):898-903. PubMed ID: 846510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of the source of hyaluronidase preparations in determining protective effect on ischemic heart muscle in acute myocardial infarction.
    Iwasaki T; Ribeiro LG; Faria DB; Cheung WM; Maroko PR
    Am Heart J; 1981 Sep; 102(3 Pt 1):324-9. PubMed ID: 7196683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of a highly purified hyaluronidase preparation on experimental myocardial infarction in the rat.
    Nilsson JE; Sjögren C; Säwe U
    Acta Med Scand; 1984; 216(2):209-13. PubMed ID: 6496178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of infarct size following coronary occlusion.
    Braunwald E; Maroko PR; Libby P
    Circ Res; 1974 Sep; 35 Suppl 3():192-201. PubMed ID: 4606996
    [No Abstract]   [Full Text] [Related]  

  • 17. Early disappearance of lymphatics draining ischemic myocardium in the dog.
    Szlavy L; Koster K; de Courten A; Hollenberg NK
    Angiology; 1987 Jan; 38(1 Pt 2):73-84. PubMed ID: 3813124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial infarction treated with two lymphagogues, calcium dobesilate (CLS 2210) and hyaluronidase: a coded, placebo-controlled animal study.
    Repa I; Garnic JD; Hollenberg NK
    J Cardiovasc Pharmacol; 1990 Aug; 16(2):286-91. PubMed ID: 1697385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term preservation of ischemic myocardium after experimental coronary artery occlusion.
    Maclean D; Fishbein MC; Braunwald E; Maroko PR
    J Clin Invest; 1978 Mar; 61(3):541-51. PubMed ID: 641137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLS 2210, hyaluronidase and the cardiac lymphatic system.
    Szlavy L; Kubik S; de Courten A; Hachen HJ; Solti F
    Angiology; 1985 Jul; 36(7):452-7. PubMed ID: 3839639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.